DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Intranasal Drug Delivery - Global Strategic Business Report" report to their offering.
This report analyzes the US market for Intranasal Drug Delivery in US$ Million by the following Therapeutic Areas: Allergic Infections, Analgesics, Osteoporosis, and Vaccinations. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for this market. Market data and analytics are derived from primary and secondary research.
The report profiles 59 companies including many key and niche players such as
- Aegis Therapeutics LLC (USA)
- AptarGroup, Inc. (USA)
- AstraZeneca Plc. (UK)
- MedImmune, Inc. (USA)
- Becton Dickinson and Company (USA)
- GlaxoSmithKline Plc. (UK)
- Johnson & Johnson Inc. (USA)
- Marina Biotech, Inc. (USA)
- Merck & Co., Inc. (USA)
- Nemera (France)
- Novartis AG (Switzerland)
- Optinose US Inc. (USA)
- Pfizer, Inc. (USA)
- Valeant Pharmaceuticals International Inc. (Canada)
Key Topics Covered:
1. Industry Overview
2. Market Drivers, Trends & Issues
3. Recent Research & Development Initiatives
4. Technology Overview
5. Nasal Drugs: An Overview
6. Product Developments, Approvals & Introductions
7. Recent Industry Activity
8. Focus On Select Global Players
9. US Market Analytics
Geographic Landscape
Total Companies Profiled: 59 (including Divisions/Subsidiaries 79)
- The United States (49)
- Canada (6)
- Japan (1)
- Europe (18)
- - France (2)
- - Germany (4)
- - The United Kingdom (7)
- - Rest of Europe (5)
- Asia-Pacific (Excluding Japan) (3)
- Latin America (1)
- Middle-East (1)
For more information visit http://www.researchandmarkets.com/research/pf2cgs/intranasal_drug
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
